Publications by authors named "Stanley Lasch"

Claim this Profile
G
Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.
Christine Bender, Peter Müller, Camilla Tondello, Jessica Horn, Martin Holdener, Stanley Lasch

J Autoimmun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Neutralization of CXCL10 Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.
Pauline Bonvin, Franck Gueneau, Vanessa Buatois, Maud Charreton-Galby, Stanley Lasch

J Biol Chem· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD3/Anti-CXCL10 Antibody Combination Therapy Induces a Persistent Remission of Type 1 Diabetes in Two Mouse Models.
Stanley Lasch, Peter Müller, Monika Bayer, Josef M Pfeilschifter, Andrew D Luster

Diabetes· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional redundancy of CXCR3/CXCL10 signaling in the recruitment of diabetogenic cytotoxic T lymphocytes to pancreatic islets in a virally induced autoimmune diabetes model.
Ken T Coppieters, Natalie Amirian, Philippe P Pagni, Carmen Baca Jones, Anna Wiberg, Stanley Lasch

Diabetes· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis